Simply Direct Medicine Review

What Simply Direct Medicine charges

Simply Direct Medicine does not publish a price today.

Simply Direct Medicine also sells 2 compounds this site boards without publishing a price for them: Glutathione and NAD+.

A price list that prices membership

The pricing page carries eight figures, and reading each one's sentence puts them against membership tiers for individuals, couples, children and families, plus two condition-specific programmes and a per-visit scheduling charge.

None of them attaches to a compound, and neither of the two tracked compounds appears on that page at all.

So this seller belongs in the group that publishes prices, and not in the group that publishes a peptide price.

The distinction is the whole point of reading each figure's own sentence rather than counting them.

A price list with an expiry date in its file name

Two documents are linked from the pricing page and both were fetched in this pass; one is a membership schedule and the other is a specials sheet.

The specials sheet's own file name carries a year and a month, and that month is the month it was read in.

A figure taken from a monthly-dated sheet stops being true on a date the reader can predict, which makes a verification date a requirement rather than a courtesy.

Nothing from either document is recorded on this row, because neither prices a compound this comparison follows.

The money question, unanswered

Its published figures price membership tiers, a scheduling charge and an aesthetic special; no compound this site tracks carries a figure anywhere.

Nothing here claims third-party testing, so there is no claim to check and no document to fail to find.

Publishing a figure somewhere on its own site is true of one hundred and thirty-seven of the two hundred and ten sellers here, so it separates far fewer of them than a reader expects.

The host itself was checked in the same pass as everything above: 404 at a nonsense path, same effective path, which is what any absence recorded here rests on.

The gaps, measured against the roster

One hundred and seventy-six of the two hundred and ten sellers here publish no state list at all, and this is one of them, so eligibility is settled inside an intake rather than before one.

Sixteen of the two hundred and ten sellers here name the facility that fills an order; this is one of the one hundred and ninety-four that do not, so there is no facility a reader can look up.

Four of the two hundred and ten sellers here describe lab work as included in what they charge, and this is not one of them.

It declares two of the sixteen compounds this site tracks, and one hundred and one sellers here declare more, so it is one of the narrower menus here.

How we verified this

• Read every page cited on this row as rendered text in a browser-equivalent fetch, with the response decompressed before any character was counted.
• Fired a nonsense-path control at this host in the same run and compared the address requested with the address actually served, so no claim here rests on a status code alone.
• Joined every text node before scanning for a dollar sign, so a figure split across nested elements could not read as an absence.
• Read each figure on the pricing page in its own sentence and found every one prices a membership tier, a scheduling charge or an aesthetic special rather than a compound.
• Fetched both linked documents and confirmed the specials sheet is a real file whose name carries the current month, so any figure from it has a predictable expiry.
• Screened this seller in the live federal warning-letter record by entity and by brand, with a known-good positive control and a nonsense negative control fired in the same run.
• Read the company column of every returned record rather than accepting a full-text match, and attached no letter on a name match.
• Swept every attribute on the pages read for a certificate, not only the link targets, because certificates in this market hide in data attributes and lightbox images.
• Re-counted the state-list, pharmacy-naming and lab-inclusion claims against the current roster rather than reusing figures from an earlier pass.